ORTEXORTEX News
Tracking CMCO? Get live short interest, options flow, and signals on ORTEX.Sign up free →
CM
Trader NoteCMCO

CMCO Surges 22% as JPMorgan Lifts Target to $30

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 3 min readdata as of 4 Nov 2026, 20:20

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Columbus McKinnon delivered its sharpest weekly gain in recent memory, jumping 22% to $18.15 after a quarterly earnings release that appears to have caught bears flat-footed.

The most immediate catalyst is an analyst move that landed on the same day as the print. JPMorgan's James Kirby raised his price target to $30 from $29 this morning, keeping an Overweight rating, putting his target 65% above the current price. That is a material vote of confidence from a bellwether firm filed within the past 24 hours. The broader analyst picture is split: DA Davidson sits at Neutral with a $17 target, now below where the stock is already trading after today's move. That divergence, one firm structurally positive and already raising, another sitting flat-footed below market price, is the clearest sign of an unsettled Street.

The bull case centres on order momentum. F4Q26 orders rose 68% year on year to $443 million, book-to-bill hit 1.01x, and the backlog climbed 61% to $520 million. The acquisition of Kito Crosby expanded scale and visibility. Bears push back on leverage: the deal pushed net debt to 5.1x with $2.6 billion of long-term debt added, and only $14 million of annualized synergies are pencilled in for FY27. EMEA and Middle East order activity remain soft, and roughly half of the company's $50 million Middle East book has been disrupted. Earnings yield ranks in the 82nd percentile on ORTEX factor scores, a signal the market is still pricing in considerable execution risk relative to what the balance sheet can carry. EV/EBIT, by contrast, scores in the 7th percentile, meaning the company looks expensive on that measure against its universe, a natural brake on re-rating enthusiasm.

Short positioning is elevated but not extreme, and this week's price action puts shorts in a difficult spot. Short interest stood at 8.7% of the free float ahead of the earnings release, up roughly 9% over the past month, with the short score edging up to 52.5 from 49.4 two weeks ago. That is a moderate reading, not a crowded short by any measure. The lending market remains loose: availability is running at roughly 1,188% of short interest, well above the 52-week low of 408%, meaning there is abundant supply for anyone looking to build or maintain a short position. Borrowing cost has risen 38% over the past week to 0.76%, which on an absolute level remains cheap. A 22% one-week move with 8.7% of the float short creates mechanical covering pressure, but the loose borrow market means no structural squeeze dynamic is in play.

Options traders were already positioned for upside before the move. The put/call ratio dropped to 0.09 on the day of the print, more than a standard deviation below its 20-day average of 0.091, indicating call interest was clearly dominating put demand. That was the market leaning into the event rather than hedging against it, and the week's outcome validated that positioning.

The ownership register adds an important structural note. CD&R XII Keystone Holdings filed a Schedule 13D in February disclosing a 42.5% stake, making it an on-register activist. That is the single largest declared position in the company and an event-driven disclosure around the 5% threshold. As the ORTEX disclosure note states, stakes are as last disclosed and positions can change without a further filing if a holder drops below 5%. Mirae Asset is the next largest holder at 10.4%, with BlackRock at 8.6%. The concentration at the top of the register means a relatively small float is doing the price discovery.

The next earnings date is pencilled in for February 3, 2027. Between now and then, what matters most is whether the Kito Crosby integration delivers the synergy timeline management has sketched out, and whether EMEA and Middle East order trends stabilise enough to support the backlog quality bears are questioning.

Stocks in this article

See the live data behind this article on ORTEX.

Open CMCO on ORTEX →

How this article was generated

Generated
4 Nov 2026, 20:21
Data as of
4 Nov 2026, 20:20
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.